The device was not returned for analysis.
A review of the lot history record revealed no manufacturing nonconformities that would have contributed to this complaint.
Additionally, a review of the complaint history of the reported lot did not indicate a lot specific quality issue.
The investigation determined the reported difficulties appear to be related to the operational context of the procedure.
There is no indication of a product quality issue with respect to manufacture, design, or labeling.
|
It was reported this was a procedure to treat a heavily calcified, heavily tortuous and 99% stenosed mid left anterior descending coronary artery.
A xience skypoint 2.
5 x 33 drug eluting stent (des) was inserted, but resistance was felt during advancement.
The stent was able to be advanced to the target lesion, but was unable to cross; therefore, the device was removed.
However, resistance was noted during removal.
A non-abbott device was then used to perform the procedure.
There were no adverse patient effects and no clinically significant delay in the procedure.
No additional information was provided.
|